Jul 30, 2015 9:35am EDT Pieris Pharmaceuticals to Host Second Quarter 2015 Investor Call on August 13th
Jul 28, 2015 5:00pm EDT Pieris Pharmaceuticals Announces Closing of Over-Allotment Option in Public Offering of Common Stock
Jul 08, 2015 8:00am EDT Pieris to Receive Seventh Milestone Payment From Daiichi Sankyo Collaboration to Develop Anticalin(R) Therapeutics
Jun 10, 2015 8:00am EDT Pieris Pharmaceuticals Completes Dosing of Healthy Volunteers in Phase I Clinical Trial for Anticalin Program in Anemia
May 19, 2015 7:30am EDT Pieris Pharmaceuticals to Present Data on Novel Anti-CD137 and HER2 Bispecific Immuno-Oncology Program at UBS Global Healthcare Conference
May 14, 2015 8:30am EDT Pieris Pharmaceuticals Appoints Immuno-Oncology Expert, Holbrook Kohrt, M.D., Ph.D., to Spearhead Immuno-Oncology Efforts and Initiates Research Collaboration with Leading Cancer Research Center
May 12, 2015 10:54am EDT Pieris Pharmaceuticals Appoints Former Celgene and Sanofi Executive, Jean-Pierre Bizzari, M.D., to Its Board of Directors
